News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,659 Results
Type
Article (41981)
Company Profile (465)
Press Release (659213)
Section
Business (208816)
Career Advice (2058)
Deals (35980)
Drug Delivery (92)
Drug Development (83326)
Employer Resources (171)
FDA (16365)
Job Trends (15083)
News (352700)
Policy (33060)
Tag
Academia (2630)
Alliances (50681)
Alzheimer's disease (1265)
Approvals (16278)
Artificial intelligence (131)
Bankruptcy (361)
Best Places to Work (11719)
Biotechnology (349)
Breast cancer (114)
Cancer (998)
Career advice (1720)
Cell therapy (224)
Clinical research (65780)
Collaboration (360)
Compensation (175)
COVID-19 (2588)
C-suite (90)
Data (959)
Diabetes (143)
Diagnostics (6202)
Earnings (85720)
Employer resources (150)
Events (112777)
Executive appointments (261)
FDA (16835)
Funding (313)
Gene therapy (168)
GLP-1 (602)
Government (4422)
Healthcare (19113)
Infectious disease (2666)
Inflammatory bowel disease (108)
Interviews (324)
IPO (16561)
Job creations (3700)
Job search strategy (1464)
Layoffs (437)
Legal (7931)
Lung cancer (162)
Manufacturing (164)
Medical device (13362)
Medtech (13367)
Mergers & acquisitions (19443)
Metabolic disorders (398)
Neuroscience (1523)
NextGen Class of 2024 (6786)
Non-profit (4559)
Northern California (1321)
Obesity (236)
Opinion (197)
Patents (97)
People (57753)
Pharmaceutical (87)
Phase I (20602)
Phase II (29028)
Phase III (21490)
Pipeline (323)
Postmarket research (2591)
Preclinical (8849)
Radiopharmaceuticals (250)
Rare diseases (205)
Real estate (6004)
Regulatory (21957)
Research institute (2423)
Resumes & cover letters (355)
Southern California (1185)
Startups (3752)
United States (12665)
Vaccines (558)
Weight loss (178)
Date
Today (242)
Last 7 days (1047)
Last 30 days (3339)
Last 365 days (36712)
2024 (32128)
2023 (41078)
2022 (52353)
2021 (56851)
2020 (55073)
2019 (47629)
2018 (35864)
2017 (33120)
2016 (32469)
2015 (38521)
2014 (32273)
2013 (27251)
2012 (29339)
2011 (29951)
2010 (28206)
Location
Africa (741)
Arizona (196)
Asia (38537)
Australia (6407)
California (3024)
Canada (1210)
China (226)
Colorado (130)
Connecticut (140)
Europe (84163)
Florida (416)
Georgia (104)
Illinois (328)
Indiana (189)
Kansas (99)
Maryland (561)
Massachusetts (2485)
Michigan (147)
Minnesota (264)
New Jersey (881)
New York (889)
North Carolina (735)
Northern California (1321)
Ohio (131)
Pennsylvania (788)
South America (1117)
Southern California (1185)
Texas (415)
Utah (86)
Washington State (347)
701,659 Results for "guided therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China
October 23, 2024
·
4 min read
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
Guided Therapeutics, Inc. (OTCQB: GTHP) announced today the completion of the clinical trial for marketing and sales approval of the Company’s LuViva Advanced Cervical Scan by the Chinese National Medical Products Administration (NMPA).
November 20, 2023
·
3 min read
Drug Development
Parkinson’s Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients’ Own Autologous Replacement Neurons
Aspen Neuroscience, Inc. announced today that it is utilizing the MRI-guided ClearPoint® Navigation System for all patients enrolled in the recently launched ASPIRO Phase 1/2a clinical trial for transplantation of dopaminergic neuron precursor cells (DANPCs) in patients with Parkinson’s Disease (PD).
June 20, 2024
·
5 min read
Press Releases
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
·
4 min read
BioCapital
Clear Guide Medical Receives FDA Clearance for CLEAR GUIDE SCENERGY™ Device for Transperineal Interventions
Clear Guide Medical proudly announces the FDA clearance for the CLEAR GUIDE SCENERGY computer aided instrument guidance system, alongside the new TP Access Tool with SteriGRID™.
March 5, 2024
·
2 min read
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
1 of 70,166
Next
